Indication: Gastroparesis

Sponsor: Neurogastrx

PI: Bob Souder, MD

Intervention/Treatment: Metopimazine mesylate and placebo

Phase: 2

Ages: 18+

Locations: Jackson, TN

Criteria: You may qualify for the study if you:

  • Have symptoms of nausea/vomiting or general discomfort (such as fullness and/or belly pain) during or after eating

Compensation: In exchange for your participation, you will receive study-related care and may be compensated for time and travel.

About: The purpose of the DRAGON study is to test investigational drug NG101 in selected adults with gastroparesis. Researchers want to compare its effect on symptoms when used at different doses in adults who have gastroparesis due to diabetes OR due to an unknown cause.

Start typing and press Enter to search